Dr. / Herr Florian / Patrick Holzapfel / Hoffmann - Net Worth and Insider Trading

Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Net Worth

The estimated net worth of Dr. / Herr Florian / Patrick Holzapfel / Hoffmann is at least $0 dollars as of 2025-06-10. Dr. / Herr Florian / Patrick Holzapfel / Hoffmann is the Supervisory Board of Cantourage Group SE and owns about 0 shares of Cantourage Group SE (FRA:HIGH) stock worth over $0. Dr. / Herr Florian / Patrick Holzapfel / Hoffmann is also the Supervisory Board of Cantourage Group SE and owns about 0 shares of Cantourage Group SE (XTER:HIGH) stock worth over $0. Details can be seen in Dr. / Herr Florian / Patrick Holzapfel / Hoffmann's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dr. / Herr Florian / Patrick Holzapfel / Hoffmann has not made any transactions after 2022-11-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Dr. / Herr Florian / Patrick Holzapfel / Hoffmann

Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dr. / Herr Florian / Patrick Holzapfel / Hoffmann owns 2 companies in total, including Cantourage Group SE (XTER:HIGH) , and Cantourage Group SE (FRA:HIGH) .

Click here to see the complete history of Dr. / Herr Florian / Patrick Holzapfel / Hoffmann’s form 4 insider trades.

Insider Ownership Summary of Dr. / Herr Florian / Patrick Holzapfel / Hoffmann

Ticker	Company	Transaction Date	Type of Owner
XTER:HIGH	Cantourage Group SE	2022-11-14	Supervisory Board
FRA:HIGH	Cantourage Group SE	2022-11-14	Supervisory Board

Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Latest Holdings Summary

Dr. / Herr Florian / Patrick Holzapfel / Hoffmann currently owns a total of 2 stocks. Among these stocks, Dr. / Herr Florian / Patrick Holzapfel / Hoffmann owns 0 shares of Cantourage Group SE (FRA:HIGH) as of November 14, 2022, with a value of $0 . Dr. / Herr Florian / Patrick Holzapfel / Hoffmann also owns 0 shares of Cantourage Group SE (XTER:HIGH) as of November 14, 2022, with a value of $0 .

Latest Holdings of Dr. / Herr Florian / Patrick Holzapfel / Hoffmann

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
FRA:HIGH	Cantourage Group SE	2022-11-14	0	6.60	0
XTER:HIGH	Cantourage Group SE	2022-11-14	0	6.52	0

Holding Weightings of Dr. / Herr Florian / Patrick Holzapfel / Hoffmann

Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Form 4 Trading Tracker

According to the SEC Form 4 filings, Dr. / Herr Florian / Patrick Holzapfel / Hoffmann has made a total of 1 transactions in Cantourage Group SE (FRA:HIGH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Cantourage Group SE is the sale of 1,750 shares on November 14, 2022, which brought Dr. / Herr Florian / Patrick Holzapfel / Hoffmann around $40,575.

According to the SEC Form 4 filings, Dr. / Herr Florian / Patrick Holzapfel / Hoffmann has made a total of 2 transactions in Cantourage Group SE (XTER:HIGH) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Cantourage Group SE is the sale of 500 shares on November 14, 2022, which brought Dr. / Herr Florian / Patrick Holzapfel / Hoffmann around $11,875.

Insider Trading History of Dr. / Herr Florian / Patrick Holzapfel / Hoffmann

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Ownership Network

Ownership Network List of Dr. / Herr Florian / Patrick Holzapfel / Hoffmann

No Data

Ownership Network Relation of Dr. / Herr Florian / Patrick Holzapfel / Hoffmann

Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Owned Company Details

What does Cantourage Group SE do?

Who are the key executives at Cantourage Group SE?

Dr. / Herr Florian / Patrick Holzapfel / Hoffmann is the Supervisory Board of Cantourage Group SE. Other key executives at Cantourage Group SE include Supervisory Board Patrick Hoffmann , Supervisory Board Dr. Florian Kainzinger , and Supervisory Board Dr. / Dr. Florian / Michael Kainzinger / Ruoff .

Cantourage Group SE (XTER:HIGH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cantourage Group SE (XTER:HIGH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cantourage Group SE (XTER:HIGH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cantourage Group SE (XTER:HIGH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cantourage Group SE Insider Transactions

No Available Data

Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Mailing Address

Above is the net worth, insider trading, and ownership report for Dr. / Herr Florian / Patrick Holzapfel / Hoffmann. Currently GuruFocus does not have mailing address information for Dr. / Herr Florian / Patrick Holzapfel / Hoffmann.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.